JP2024515346A - 立体構造スイッチングナノ構造体 - Google Patents

立体構造スイッチングナノ構造体 Download PDF

Info

Publication number
JP2024515346A
JP2024515346A JP2023564438A JP2023564438A JP2024515346A JP 2024515346 A JP2024515346 A JP 2024515346A JP 2023564438 A JP2023564438 A JP 2023564438A JP 2023564438 A JP2023564438 A JP 2023564438A JP 2024515346 A JP2024515346 A JP 2024515346A
Authority
JP
Japan
Prior art keywords
nanostructure
coupling
molecule
entity
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023564438A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024515346A5 (cg-RX-API-DMAC7.html
Inventor
エンゲレン、ワウター
シグル、クリスチャン
ディーツ、ヘンドリック
Original Assignee
テクニッシェ ウニベルシタット ミュンヘン
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テクニッシェ ウニベルシタット ミュンヘン filed Critical テクニッシェ ウニベルシタット ミュンヘン
Publication of JP2024515346A publication Critical patent/JP2024515346A/ja
Publication of JP2024515346A5 publication Critical patent/JP2024515346A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/35—Valency

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP2023564438A 2021-04-22 2022-04-22 立体構造スイッチングナノ構造体 Pending JP2024515346A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21169934.3A EP4079330A1 (en) 2021-04-22 2021-04-22 Conformation switching nanostructures
EP21169934.3 2021-04-22
PCT/EP2022/060737 WO2022223802A1 (en) 2021-04-22 2022-04-22 Conformation switching nanostructures

Publications (2)

Publication Number Publication Date
JP2024515346A true JP2024515346A (ja) 2024-04-09
JP2024515346A5 JP2024515346A5 (cg-RX-API-DMAC7.html) 2025-05-01

Family

ID=75659780

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023564438A Pending JP2024515346A (ja) 2021-04-22 2022-04-22 立体構造スイッチングナノ構造体

Country Status (6)

Country Link
US (1) US20240199763A1 (cg-RX-API-DMAC7.html)
EP (2) EP4079330A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024515346A (cg-RX-API-DMAC7.html)
KR (1) KR20230175241A (cg-RX-API-DMAC7.html)
CN (1) CN117222437A (cg-RX-API-DMAC7.html)
WO (1) WO2022223802A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4399528A1 (en) 2021-09-09 2024-07-17 Nautilus Subsidiary, Inc. Characterization and localization of protein modifications
EP4764494A1 (en) * 2024-12-20 2026-06-24 Plectonic Biotech GmbH Conjugates for analyte detection and quantification

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020254684A1 (en) * 2019-06-21 2020-12-24 Tilibit Nanosystems Gmbh Conditionally switchable nanostructure

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020254684A1 (en) * 2019-06-21 2020-12-24 Tilibit Nanosystems Gmbh Conditionally switchable nanostructure

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NATURE COMMUNICATIONS, vol. 10, JPN6026009215, 2019, pages 1 - 9, ISSN: 0005813181 *
NATURE COMMUNICATIONS, vol. 2, JPN6026009212, 2011, pages 1 - 8, ISSN: 0005813182 *

Also Published As

Publication number Publication date
US20240199763A1 (en) 2024-06-20
EP4326342A1 (en) 2024-02-28
CN117222437A (zh) 2023-12-12
KR20230175241A (ko) 2023-12-29
WO2022223802A1 (en) 2022-10-27
EP4079330A1 (en) 2022-10-26

Similar Documents

Publication Publication Date Title
van der Meel et al. Next-generation materials for nucleic acid delivery
Jain et al. Comparison of avidin, neutravidin, and streptavidin as nanocarriers for efficient siRNA delivery
Céspedes et al. In vivo architectonic stability of fully de novo designed protein-only nanoparticles
US9297013B2 (en) pRNA multivalent junction domain for use in stable multivalent RNA nanoparticles
Pawar et al. Current update on transcellular brain drug delivery
He et al. Peptide-induced self-assembly of therapeutics into a well-defined nanoshell with tumor-triggered shape and charge switch
Serna et al. Rational engineering of single-chain polypeptides into protein-only, BBB-targeted nanoparticles
Serrano et al. DNA-peptide amphiphile nanofibers enhance aptamer function
Tong et al. Optimizing peptide-conjugated lipid nanoparticles for efficient siRNA delivery across the blood–brain barrier and treatment of glioblastoma multiforme
US20190117572A1 (en) Microfluidic-formulated leukosome compositions and fabrication methods therefor
US20240199763A1 (en) Conformation switching nanostructures
Shi et al. Virus mimetic framework DNA as a non-LNP gene carrier for modulated cell endocytosis and apoptosis
CN104395475B (zh) 基于jcv-病毒样颗粒的新型药物递送系统
Pottash et al. Protein-based vehicles for biomimetic RNAi delivery
EP2864345B1 (en) Particle-nucleic acid conjugates and therapeutic uses related thereto
Xiao et al. In vivo interactions of nucleic acid nanostructures with cells
Li et al. Intranuclear delivery of DNA nanostructures via cellular mechanotransduction
Kanwar et al. Applications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseases
Qian et al. Recent Progress in Gene Delivery Systems Based on Gemini‐Surfactant
Zhang et al. Exploring the effect of drug loading on the biological fate of polymer-coated solid nanoparticles
Noble et al. Folding-mediated DNA delivery by α-helical amphipathic peptides
Covarrubias-Zambrano et al. Development of a gene delivery system composed of a cell-penetrating peptide and a nontoxic polymer
CN119998457A (zh) 基于金属纳米颗粒-核酸缀合物的基因载体
Wang et al. RNA binding protein as monodisperse carriers for siRNA delivery
Zabel et al. Lipopeptide delivery of siRNA to the central nervous system

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20240220

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20240220

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250421

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250421

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260310

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20260414